Literature DB >> 27757581

Secretagogue-dependent and -independent transport of zinc hydration forms in rat parietal cells.

Florentina Sophie Ferstl1,2, Alice Miriam Kitay1,3, Rebecca Marion Trattnig1,2, Abrar Alsaihati1, John Peter Geibel4,5.   

Abstract

Prolonged exposure to gastric acid is a leading cause of gastroesophageal reflux disease (GERD) and esophagitis. With the ever increasing number of patients showing insensitivity to proton-pump-inhibitor (PPI) therapy with recurrence of symptoms over time, alternative treatment options remain an important issue. Previous studies from our laboratory have shown that a zinc sulfate salt can inhibit HCl generation at the cellular level of the parietal cell. In this paper, we examine the difference between two hydration forms of ZnSO4 (monohydrate H2O and heptahydrate 7H2O) in their entry characteristics into the parietal cell under several physiological conditions associated with acid secretion. Using the Zn sensitive fluorochrome Newport Green, we examined the rate of Zn entry in Δfluorescent units/second (ΔFU/second), at two different concentrations for both hydration states on both fasted and non-fasted animals. In a separate series of studies, we examined the effects of secretagogues on the entry rates and transport mechanisms. Exposure of the secretagogue carbachol transformed the resting parietal cell to an activated state and represents a stimulated condition through the neuronal pathway. The hormonal activation of the parietal cell was achieved by using histamine. Non-fasted conditions were considered to be a state between hormonal and neuronal activation. To demonstrate that ZnSO4 enters the parietal cell through the NKCC1 co-transporter, the inhibitor bumetanide was applied during secretagogue-stimulated acid secretion. Both salts, monohydrate and heptahydrate ZnSO4, show a concentration-dependent cell entry under all conditions studied. During stimulated acid secretion, induced through either the neuronal or the hormonal pathway, heptahydrate ZnSO4 enters the parietal cell significantly faster than monohydrate ZnSO4, whereas monohydrate ZnSO4 exhibits faster entry during resting conditions in fasted animals. At 30 μM following stimulation with histamine, heptahydrate ZnSO4 enters the cell faster than monohydrate ZnSO4 (ΔFU/second 30 μM ZnSO4*7H2O + histamine = 1.782, ΔFU/second 30 μM ZnSO4*H2O+histamine = 1.038, respectively). Three hundred micromolar, heptahydrate ZnSO4 shows a faster entry into the cells (ΔFU/second ZnSO4*7H2O300μM + carbachol = 4.02407) compared to monohydrate ZnSO4 (ΔFU/second ZnSO4*H2O300μM + carbachol = 3.225) following exposure to carbachol. The mechanism of entry of both salts was found to be predominantly via the basolateral NKCC1 transporter with the rate of zinc entry decreasing to minimal values (ΔFU/second = 0.275) after application of bumetanide during stimulated conditions.

Entities:  

Keywords:  Bumetanide; Gastric acid secretion; NKCC1 co-transporter; Newport green; Stomach

Mesh:

Substances:

Year:  2016        PMID: 27757581     DOI: 10.1007/s00424-016-1889-3

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  30 in total

1.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

2.  Risk factors associated with symptoms of gastroesophageal reflux.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

3.  Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.

Authors:  P L Peghini; P O Katz; N A Bracy; D O Castell
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

4.  Activation of the Na-K-Cl cotransporter NKCC1 detected with a phospho-specific antibody.

Authors:  Andreas W Flemmer; Ignacio Gimenez; Brian F X Dowd; Rachel B Darman; Biff Forbush
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

Review 5.  Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure.

Authors:  Ronnie Fass
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Gastric acid, calcium absorption, and their impact on bone health.

Authors:  Sascha Kopic; John P Geibel
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

7.  Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Authors:  P Michael Ho; Thomas M Maddox; Li Wang; Stephan D Fihn; Robert L Jesse; Eric D Peterson; John S Rumsfeld
Journal:  JAMA       Date:  2009-03-04       Impact factor: 56.272

8.  Novel approaches to inhibition of gastric acid secretion.

Authors:  George Sachs; Jai Moo Shin; Richard Hunt
Journal:  Curr Gastroenterol Rep       Date:  2010-12

Review 9.  Acid secretion and the H,K ATPase of stomach.

Authors:  C Prinz; M Kajimura; D Scott; H Helander; J Shin; M Besancon; K Bamberg; S Hersey; G Sachs
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec

10.  Proton Pump Inhibitors Interfere With Zinc Absorption and Zinc Body Stores.

Authors:  Christopher P Farrell; Melissa Morgan; David S Rudolph; Austin Hwang; Nicole E Albert; Mary C Valenzano; Xuexuan Wang; Giancarlo Mercogliano; James M Mullin
Journal:  Gastroenterology Res       Date:  2011-11-20
View more
  1 in total

1.  Induction of Secretagogue Independent Gastric Acid Secretion via a Novel Aspirin-Activated Pathway.

Authors:  Alice Miriam Kitay; Florentina Sophie Ferstl; Alexander Link; John Peter Geibel
Journal:  Front Physiol       Date:  2019-10-10       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.